Less Ads, More Data, More Tools Register for FREE

Pin to quick picksClose Bros Regulatory News (CBG)

Share Price Information for Close Bros (CBG)

Share Price is delayed by 15 minutes
Get Live Data
407.00    0.80 (0.20%)
Bid:
405.00
Ask:
405.40
Spread: 0.40 (0.099%)
Market Cap: £613.40m
CBG Live PriceLast checked at - London Stock Exchange

Intraday Close Bros Share Chart

Scheduled Trading Update

22 Jan 2019 07:00

RNS Number : 6874N
Close Brothers Group PLC
22 January 2019
 

 

Scheduled Trading Update

Close Brothers Group plc ("the group" or "Close Brothers") today issues its scheduled pre-close trading update ahead of its 2019 half year end. Close Brothers will be releasing its half year results for the six months ending 31 January 2019 on 12 March 2019.

All statements in this release relate to continuing operations1 over the five months to 31 December 2018 unless otherwise indicated.

Group and divisional performance

The group has achieved a solid performance overall, notwithstanding the difficult trading conditions for our market facing businesses.

The Banking division has continued to perform well and in line with expectations, as we focus on maintaining our disciplined approach to lending and investing to maximise the long-term potential of our businesses.

The loan book grew 3.1% in the period to £7.5 billion (1 August 2018: £7.2 billion2), driven by good new business volumes across the Commercial businesses and in Premium Finance.

Impairment charges remained low, with strong credit performance across all businesses. The net interest margin has remained broadly stable since the last financial year, reflecting our continued pricing discipline.

Winterflood has continued to deliver solid profitability, but volumes and trading income have been significantly lower than the prior year reflecting difficult and volatile equity market conditions, particularly in December.

Asset Management has continued to achieve good net inflows, although these were more than offset by negative market movements, resulting in a 3% decline in managed assets to £10.0 billion at 31 December 2018 (31 July 2018: £10.4 billion) and a decrease in total client assets to £11.7 billion (31 July 2018: £12.2 billion).

Outlook

Overall, we expect a solid outcome for the first half, and remain well positioned for the remainder of the financial year.

 

1 Results from continuing operations exclude the unsecured retail point of sale finance business, which was classified as a discontinued operation in the group's 2018 financial statements.

2 The opening net loan book of £7,239 million reflects the adoption of IFRS 9 at 1 August 2018. For further details see the group's IFRS 9 transition document published on 7 November 2018.

 

 

Enquiries

 

Sophie Gillingham

Close Brothers Group plc

020 7655 3844

Matt Bullivant

Close Brothers Group plc

020 7655 3698

Declan Simpson

Close Brothers Group plc

020 7655 3632

Andy Donald

Maitland

020 7379 5151

 

About Close Brothers

Close Brothers is a leading UK merchant banking group providing lending, deposit taking, wealth management services and securities trading. We employ around 3,300 people, principally in the UK. Close Brothers Group plc is listed on the London Stock Exchange and is a member of the FTSE 250.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTCKDDPABKDNDB
Date   Source Headline
1st Dec 20174:00 pmRNSDirector/PDMR Shareholding
1st Dec 20173:58 pmRNSTransaction in Own Shares
30th Nov 20175:56 pmRNSTotal Voting Rights
30th Nov 20175:56 pmRNSShare Purchase
30th Nov 201712:36 pmRNSShare Purchase
30th Nov 20179:31 amRNSDirector/PDMR Shareholding
27th Nov 20175:42 pmRNSTransaction in Own Shares
27th Nov 20173:48 pmRNSDirector/PDMR Shareholding
22nd Nov 20177:30 amRNSPresentation to Analysts and Investors
17th Nov 20177:00 amRNSAGM Special Business
16th Nov 20175:00 pmRNSResult of AGM
16th Nov 20177:00 amRNSScheduled Trading Update
10th Nov 20174:42 pmRNSHolding(s) in Company
10th Nov 20174:35 pmRNSHolding(s) in Company
7th Nov 20175:49 pmRNSDirector/PDMR Shareholding
1st Nov 20174:21 pmRNSHolding(s) in Company
31st Oct 20175:04 pmRNSBlock listing Interim Review
31st Oct 20175:02 pmRNSTotal Voting Rights
31st Oct 20172:43 pmRNSHolding(s) in Company
30th Oct 201710:20 amRNSHolding(s) in Company
27th Oct 20179:31 amRNSDirector/PDMR Shareholding
26th Oct 20175:00 pmRNSDirector/PDMR Shareholding
25th Oct 20172:58 pmRNSDirector/PDMR Shareholding
24th Oct 201711:04 amRNSHolding(s) in Company
23rd Oct 20173:05 pmRNSTransaction in Own Shares
23rd Oct 201711:22 amRNSHolding(s) in Company
18th Oct 201712:17 pmRNSDirector/PDMR Shareholding
17th Oct 20172:28 pmRNSNotice Of Quarterly Trading Update
16th Oct 20174:51 pmRNSTransaction in Own Shares
16th Oct 20174:49 pmRNSDirector/PDMR Shareholding
13th Oct 20174:40 pmRNSHolding(s) in Company
12th Oct 20176:02 pmRNSAGM Documents
10th Oct 201712:16 pmRNSDirector/PDMR Shareholding
9th Oct 20175:06 pmRNSDirector/PDMR Shareholding
9th Oct 20175:04 pmRNSTransaction in Own Shares
6th Oct 20173:26 pmRNSDirector/PDMR Shareholding
6th Oct 201710:53 amRNSDirector/PDMR Shareholding
4th Oct 20175:57 pmRNSDirector/PDMR Shareholding
4th Oct 20175:41 pmRNSDirector/PDMR Shareholding
4th Oct 20175:41 pmRNSDirector/PDMR Shareholding
4th Oct 20175:40 pmRNSDirector/PDMR Shareholding
2nd Oct 20172:57 pmRNSTransaction in Own Shares
2nd Oct 201711:18 amRNSAnnual Financial Report
29th Sep 20175:20 pmRNSDirector/PDMR Shareholding
29th Sep 20175:04 pmRNSTotal Voting Rights
26th Sep 20177:00 amRNSPreliminary results for year ended 31 July 2017
25th Sep 20171:54 pmRNSTransaction in Own Shares
18th Sep 20175:00 pmRNSTransaction in Own Shares
11th Sep 201712:12 pmRNSHolding(s) in Company
6th Sep 20175:08 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.